First, using the Tumor Immune Estimation Resource (TIMER) database, we found that the majority of tumor tissues had higher levels of GCS1 expression than did the counterpart normal tissues, particularly for cases of colon and rectal cancer (Fig. 1A). Here, MOGS is linked to rectal cancer.